Searched for: subject%3A%22Drug%255C%2BApproval%22
(1 - 3 of 3)
Turner, M.A. (author), Mooij, M.G. (author), Vaes, W.H.J. (author), Windhorst, A.D. (author), Hendrikse, N.H. (author), Knibbe, C.A.J. (author), Körgvee, L.T. (author), Maruszak, W. (author), Grynkiewicz, G. (author), Garner, R.C. (author), Tibbocl, D. (author), Park, B.K. (author), de Wildt, S.N. (author)
Important information gaps remain on the efficacy and safety of drugs in children. Pediatric drug development encounters several ethical, practical, and scientifîc chaflenges One barrier to the evaluation of medicines for children is a lack of Innovative methodologies that have been adapted to the needs of chiIdren This article presents our...
article 2015
Hopkins, M.M. (author), Ibarreta, D. (author), Gaisser, S. (author), Enzing, C.M. (author), Ryan, J. (author), Martin, P.A. (author), Lewis, G. (author), Detmar, S. (author), van den Akker-van Marle, M.E. (author), Hedgecoe, A.M. (author), Nightingale, P. (author), Dreiling, M. (author), Hartig, K.J. (author), Vullings, W. (author), Forde, T. (author)
article 2006
van der Greef, J. (author), McBurney, R.N. (author), TNO Kwaliteit van Leven (author)
The pharmaceutical industry is currently beleaguered by close scrutiny from the financial community, regulators and the general public. Productivity, in terms of new drug approvals, has generally been falling for almost a decade and the safety of a number of highly successful drugs has recently been brought into question. Here, we discuss...
article 2005